Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive Optics Imaging of Outer Retinal Diseases

NCT05355415 is registered in ClinicalTrials.gov with Food and Drug Administration (FDA) as lead sponsor.

NCT NCT05355415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05355415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive Optics Imaging of Outer Retinal Diseases
Lead sponsor
Food and Drug Administration (FDA)
Phase
Observational
Overall status
Recruiting
Start date
August 27, 2021
Completion date
September 30, 2028
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, cone dystrophy, cone rod dystrophy, hydroxychloroquine retinopathy, late-onset retinal degeneration, retinal degeneration, retinitis pigmentosa, rod cone dystrophy, rod dystrophy, usher syndromes